JAVEMACS: a real-world study of avelumab maintenance therapy for advanced urothelial carcinoma in Japan

H. Kitamura, T. Kobayashi, Y. Endo, M. Ikeda, K. Yonemori, M. Nakayama, A. Fujihara, T. Abe, F. Shimizu, K. Fujimoto, T. Nakagawa, S. Hatakeyama, K. Murakami, K. Nishihara, D. Ikarashi, N. Masumori, S. Naito, K. Fujita, N. Hayakawa, T. Hara, N. Miura, T. Negishi, J. Yatsuda, M. Kobayashi, N. Nishiyama, R. Taoka, J. Furukawa, M. Shono, S. Shirotake, E. Kikuchi

Open source

DOI: 10.1016/j.esmorw.2025.100646
Published: 2025-12
Container: ESMO Real World Data and Digital Oncology
Publisher: Elsevier BV
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.esmorw.2025.100646,
  title = {JAVEMACS: a real-world study of avelumab maintenance therapy for advanced urothelial carcinoma in Japan},
  author = {H. Kitamura and T. Kobayashi and Y. Endo and M. Ikeda and K. Yonemori and M. Nakayama and A. Fujihara and T. Abe and F. Shimizu and K. Fujimoto and T. Nakagawa and S. Hatakeyama and K. Murakami and K. Nishihara and D. Ikarashi and N. Masumori and S. Naito and K. Fujita and N. Hayakawa and T. Hara and N. Miura and T. Negishi and J. Yatsuda and M. Kobayashi and N. Nishiyama and R. Taoka and J. Furukawa and M. Shono and S. Shirotake and E. Kikuchi},
  year = {2025},
  journal = {ESMO Real World Data and Digital Oncology},
  doi = {10.1016/j.esmorw.2025.100646},
  url = {https://doi.org/10.1016/j.esmorw.2025.100646}
}

RIS

TY  - JOUR
TI  - JAVEMACS: a real-world study of avelumab maintenance therapy for advanced urothelial carcinoma in Japan
AU  - H. Kitamura
AU  - T. Kobayashi
AU  - Y. Endo
AU  - M. Ikeda
AU  - K. Yonemori
AU  - M. Nakayama
AU  - A. Fujihara
AU  - T. Abe
AU  - F. Shimizu
AU  - K. Fujimoto
AU  - T. Nakagawa
AU  - S. Hatakeyama
AU  - K. Murakami
AU  - K. Nishihara
AU  - D. Ikarashi
AU  - N. Masumori
AU  - S. Naito
AU  - K. Fujita
AU  - N. Hayakawa
AU  - T. Hara
AU  - N. Miura
AU  - T. Negishi
AU  - J. Yatsuda
AU  - M. Kobayashi
AU  - N. Nishiyama
AU  - R. Taoka
AU  - J. Furukawa
AU  - M. Shono
AU  - S. Shirotake
AU  - E. Kikuchi
PY  - 2025
JO  - ESMO Real World Data and Digital Oncology
DO  - 10.1016/j.esmorw.2025.100646
UR  - https://doi.org/10.1016/j.esmorw.2025.100646
ER  -

APA

Kitamura, H., Kobayashi, T., Endo, Y., Ikeda, M., Yonemori, K., Nakayama, M., Fujihara, A., Abe, T., Shimizu, F., Fujimoto, K., Nakagawa, T., Hatakeyama, S., Murakami, K., Nishihara, K., Ikarashi, D., Masumori, N., Naito, S., Fujita, K., Hayakawa, N., Hara, T., Miura, N., Negishi, T., Yatsuda, J., Kobayashi, M., Nishiyama, N., Taoka, R., Furukawa, J., Shono, M., Shirotake, S., & Kikuchi, E. (2025). JAVEMACS: a real-world study of avelumab maintenance therapy for advanced urothelial carcinoma in Japan. ESMO Real World Data and Digital Oncology. https://doi.org/10.1016/j.esmorw.2025.100646

Source records

crossref · retrieved 2026-09-25T18:18:00.958Z